Statistics for A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients

Total visits

views
A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients 3

Total visits per month

views
septiembre 2024 0
octubre 2024 0
noviembre 2024 0
diciembre 2024 0
enero 2025 0
febrero 2025 0
marzo 2025 0

File Visits

views
a_randomized,_open_label_study_of_a_nucleoside.16.pdf 2